India's Alkem Laboratories falls after CEO resigns
24/04/2026 10:43
** Shares of India's Alkem Laboratories ALKE.NS down 4.15% to 5,288 rupees ** Pharmaceutical firm's CEO Vikas Gupta steps down from his position ** ALKE rated "hold" on avg by 19 analysts; median TP 5,890 rupees ** YTD stock up 0.25% (Reporting by Devika Nair in Bengaluru) ((Devika.MadhusudhananNair@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees